Observational study for evaluation of effecacy and safety of ethinylestradiol therapy for postmenopausal hormone receptor-positive metastatic breast cancer patients heavily pre-treated with endocrine treatment
Not Applicable
- Conditions
- Breast Cancer
- Registration Number
- JPRN-UMIN000010492
- Lead Sponsor
- Study group for metastatic breast cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- Female
- Target Recruitment
- 65
Inclusion Criteria
Not provided
Exclusion Criteria
1. History of deep vain thrombosis, myocardial infarction and brain infarction 2. Active double cancer, history of endometrial cancer and History of other cancer within 5 years (exclued in-situ cervical cancer, basal cell carcinoma and squamous cell carcinoma of the skin) 3. HER2-positive breast cancer 4. Bilateral breast cancer 5. inflamatory breast cancer 6. History of sever drug hypersensitivity 7. pregnant or nursing female 8. life-threatening metastatic breast cancer 9. The case which the family doctor judged to be unsuitable for the object of the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical benefit rate
- Secondary Outcome Measures
Name Time Method Objective response rate, progression-free survival, adverse events, endocrine-related symptoms